20285 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
Sesquiterpenoid-based compounds, extracts of comprising the same, and use thereof
#302MetAP-2 inhibitor polymersomes for therapeutic administration
#303Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
#304Method for producing composition containing fucoxanthin
#305COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION
#306Therapeutic curcumin derivatives
#307Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma
#308Methods of treating age related disorders
#309Synergistic Combination Therapy
#310MetAP-2 inhibitor polymersomes for therapeutic administration
#311Pharmaceutical compositions of dimethyl fumarate
#312Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
#313Compositions and methods for inhibiting proteases
#314BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE
#315Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme
#316MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#317Tiglien-3-one derivatives
#318Use of cathepsin K inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure
#319Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
#320Methods of treating giardiasis
#321Selecting use of proteasome inhibitors based on NF-κB2 sequence
#322Conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
#323Methods and composition for Treating Thyroid Hormone Related Disorders
#324Expression Modulator For Clock Gene
#325Use of compounds isolated from for treating cancer and/or thrombocytopenia
#326Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol
#327Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol
#328Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol
#329Composition of monoterpenoids having bactericidal properties
#330Methods of Treating Obesity Using an Effective Dose of a METAP-2 Inhibitor
#331Methods of Reducing Risk of Hepatobiliary Dysfunction During Rapid Weight Loss with METAP-2 Inhibitors
#332COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
#333Tricyclic lactones for treatment of cancer
#334O-nitro compounds and pharmaceutical compositions including same
#335Methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
#336Medicament for LCT poisoning
#337METHODS OF TREATING AN OVERWEIGHT SUBJECT
#338Expression Modulator For Clock Gene
#339NEURONAL CIRCUIT-DEPENDENT NEUROPROTECTION BY INTERACTION BETWEEN NICOTINIC RECEPTORS
#340Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (−)-carvone, geraniol and a further essential oil component
#341Method of reducing weight using composition containing fucoxanthin extract
#342Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#343Cancer therapy
#344Methods and compositions for malic enzyme 2 (ME2) as a target for cancer therapy
#345Use of fucoxanthin in the preparation of product for improving memory and having neuroprotective effect associated with neurodegenerative disorder
#346Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
#347Improving efficacy of cancer therapy
#348Methods and compositions for improving the health of animals
#349Prodrug compositions, prodrug nanoparticles, and methods of use thereof
#350METHODS OF CARDIOVASCULAR PATIENT TREATMENT USING SUBSTANCES SUFFICIENT TO REDUCE ACTIN DEPOLYMERIZATION
#351Treatment of viral infections by modulation of host cell metabolic pathways
#352Methods of treating a subject with benign prostate hyperplasia
#353USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, and NK2 RECEPTORS
#354Use of peptide epoxyketones for metastasis suppression
#355Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
#356Methods and Compositions for Treating Cardiovascular Disorders
#357METHODS AND COMPOSITIONS FOR MALARIA PROPHYLAXIS
#358Fumigillol type compounds and methods of making and using same
#359Prophylactic or Therapeutic Agent For Gum Disease or Apical Periodontitis
#360Compositions and methods for modulating metabolic pathways
#361Compositions and methods for modulating metabolic pathways
#362Methods of treating an overweight or obese subject
#363Crystalline solids of a MetAP-2 inhibitor and methods of making and using same
#364Synergistic Combination Therapy
#365Rapid opioid detoxification
#366Pharmaceutical compositions of O-nitro compounds
#367PREPARATION OF CAROTENOID DERIVATIVES AND THEIR APPLICATIONS
#368Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same
#369COMPOSITIONS AND METHODS FOR ORGAN PRESERVATION
#370COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED ALPHA-SYNUCLEIN FUNCTION
#371Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB)
#372MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#373Methods of treating an overweight or obese subject
#374Methods of Treating an Overweight or Obese Subject
#375Methods for enhancing hematopoietic stem/progenitor cell engraftment
#376Optimized Drug Conjugates
#377HISTONE DEACETYLASE INHIBITORS
#378Conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
#379Combination therapy for the prevention of statin induced diabetes
#380Compositions containing fucoxanthin extract
#381Antibacterial combination therapy for the treatment of gram positive bacterial infections
#382INHIBITORS OF EPOXIDE HYDROLASES FOR THE TREATMENT OF HYPERTENSION
#383METHODS AND COMPOSITIONS FOR MALARIA PROPHYLAXIS
#384Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial Dysfunction
#385COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
#386Inhibitors of carnitin-palmitoyl-tranferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
#387USE OF FUMAGILLIN AND THE DERIVATIVES THEREOF TO INCREASE THE BIOAVAILABILITY OF THE MACROCYCLIC LACTONES
#388Method of treatment for cancers associated with elevated HER2 levels
#389COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES
#390THERAPEUTIC OR PROPHYLACTIC AGENT FOR CEREBRAL ANEURYSM
#391Synergistic anticoagulant composition
#392METHOD OF SLOWING THE AGING PROCESS BY ACTIVATING SIRTUIN ENZYMES
#393Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
#394TARGETED ATHEROSCLEROSIS TREATMENT
#395REGULATOR FOR SIGNALING TOLL-LIKE RECEPTOR, WHICH COMPRISES CATHEPSIN INHIBITOR AS ACTIVE INGREDIENT
#396Methylated curcumin-resveratrol hybrid molecules for treating cancer
#397USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS
#398Ethanol Enhances the Complete Replication of Hepatitis C Virus: the Role of Acetaldehyde
#399COMPOSITION FOR PREVENTING OR TREATING LIPID METABOLIC DISORDERS COMPRISING FUCOXANTHIN OR MARINE PLANT EXTRACT CONTAINING SAME
#400METHOD OF TREATING AUTOIMMUNE DISEASES
#401THERAPEUTIC AGENT FOR VIRUS-ASSOCIATED MALIGNANCY
#402Preparation of Fine Particles
#403TERPENES WITH ANTIFUNGAL ACTIVITY AGAINST MALASSEZIA YEASTS
#404Method for the asymmetric synthesis of beta-lactone compounds
#405Nonlinear variable lag smoother
#406MetAP-2 inhibitor polymersomes for therapeutic administration
#407Method for producing fucoxanthin
#408METHODS AND COMPOSITIONS FOR REDUCING INFLAMMATION AND TREATING INFLAMMATORY DISORDERS
#409VAGINAL ODORANTS
#410METHODS AND COMPOSITIONS FOR MALARIA PROPHYLAXIS
#411MetAP-2 inhibitor polymersomes for therapeutic administration
#412ANTI-INFLAMMATORY AND PSORIASIS TREATMENT AND PROTEIN KINASE INHIBITION BY HYDROXY STILBENES AND NOVEL STILBENE DERIVATIVES AND ANALOGUES
#413ANTI-OBESITY ACTIVE AGENT AND ANTI-OBESITY METHOD
#414Novel Composition for Tumor Growth Control
#415Forskolin Compositions and Methods For Administration
#416Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors
#417USE OF HEAT SHOCK TO TREAT OCULAR DISEASE
#418Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction
#419Methods of treating an overweight or obese subject
#420MEDICAMENT FOR LCT POISONING
#421Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
#422Treatment of viral infections by modulation of host cell metabolic pathways
#423Methods of treating pain
#424Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy
#425Tiglien-3-one derivatives
#426METHODS AND COMPOSITIONS FOR MALARIA PROPHYLAXIS
#427METHOD FOR TREATING INFLUENZA VIRUS INFECTION
#428Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation
#429Methods of inhibiting or suppressing cellular proliferation
#430Novel Pharmaceutical
#431CURCUMIN AND CURCUMINOID INHIBITION OF ANGIOGENESIS
#432Use of Cis-Epoxyeicosatrienoic Acids And Inhibitors of Soluble Epoxide Hydrolase to Alleviate Eye Disorders
#433Physiologically active substances
#434REMEDY OR PREVENTIVE FOR KIDNEY DISEASE AND METHOD OF DIAGNOSING KIDNEY DISEASE
#435Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxystilbenes and Novel Stilbene Derivatives and Analogues
#436Physiologically active substances
#437Composition and method of use for the treatment of metabolic syndrome and inflammation
#438Use Of Fumagillin And The Derivatives Thereof To Increase The Bioavilability Of The Macrocyclic Lactones
#439Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues
#440Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
#441THERAPEUTIC AGENT FOR VIRUS-ASSOCIATED MALIGNANCY
#442Agents for the treatment of viral infections
#443Methods for treating bone associated diseases by the use of methionine aminopeptidase-2 inhibitors
#444Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
#445Treatment of degenerative cartilage conditions in a mammal with Glycosidasc Inhibitors
#446Neuroactive substance and uses of one such substance
#447Macrophage activation inhibitor
#448Methods to ameliorate and image angioplasty-induced vascular injury
#449O-nitro compounds, pharmaceutical compositions thereof and uses thereof
#450Method and composition for treating obesity by targeting cathespin
#451Novel uses of known drugs
#452Therapeutic agent for iNOS generating illness
#453Therapeutic curcumin derivatives
#454Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents
#455Histone deacetylase inhibitors
#456Use of Inhibitors of the Ubiquitin Proteasome Pathway as a Method of Increasing Contractility of the Heart
#457Targeted atherosclerosis treatment
#458Remedy or preventive for kidney disease and method of diagnosing kidney disease
#459Method for modulating process mediated by farnesoid activated receptors
#460Composition containing artemisinin for treatment of malaria
#461Method for the asymmetric synthesis of beta-lactone compounds
#462Physiologically active substances
#463Method and composition for reducing blood sugar levels or fat storage by targeting cathepsin
#464Cancer treatment with epothilones
#465Drug composition containing nf-kb inhibitor
#466Method of treating autoimmune diseases
#467Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors
#468Aza-peptide epoxides
#469Medicinal composition
#470Use of a composition comprising vitamin K1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions
#471Use of cis-epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce damage from stroke
#472Method of producing macrolide compound
#473Composition for enzyme inhibition
#474Methods and compositions for malaria prophylaxis
#475Vulnerable plaque treatment
#476Novel inhibitors of ubiquitin isopeptidases
#477Hypoestoxides, derivatives and agonists thereof for use in the prophylaxis and treatment of obesity
#478Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases
#479Bioactive substance
#480Low oil emulsion compositions for delivering taxoids and other insoluble drugs
#481Connexin 26 inhibitor and cancer metastasis inhibitors
#482Inhibitors of epoxide hydrolases for the treatment of hypertension
#483Method of treating autoimmune diseases
#484Novel physiologically active substances
#485Forskolin compositions and methods for administration
#486Inhibitors of epoxide hydrolases for the treatment of hypertension
#487Ceramide de novo synthesis-based therapeutic and prophylactic methods, and related articles of manufacture
#488Pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one
#489Il-6 production inhibitors
#490Hypoestoxides, derivatives, agonists and crude extracts thereof for use in cosmetic compositions
#491Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues
#492Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
#493Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction
#494Compositions and methods for modulating metabolic pathways
#495Methods of killing bacteria and preventing or treating bacterial infection with oxidation products of safranal and methods of synthesizing safranal epoxides
#496Green synthesis of reduced graphene oxide using seed extract
#497Composition for regulation of liver X receptor